|
BCAP29 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62436730732907E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
2.10579999999627E-05 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.62436730732907E-12 |
| Stage1-vs-Stage2 |
3.382500E-03 |
| Stage1-vs-Stage3 |
8.120300E-02 |
| Stage1-vs-Stage4 |
1.940500E-03 |
| Stage2-vs-Stage3 |
3.372900E-04 |
| Stage2-vs-Stage4 |
2.02939999999208E-05 |
| Stage3-vs-Stage4 |
2.315000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
1.66660019118581E-11 |
| Normal-vs-Asian |
1.62447832963153E-12 |
| Caucasian-vs-AfricanAmerican |
6.916600E-01 |
| Caucasian-vs-Asian |
4.119600E-01 |
| AfricanAmerican-vs-Asian |
9.133400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62436730732907E-12 |
| Male-vs-Female |
4.187400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(41-60Yrs) |
1.62436730732907E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62436730732907E-12 |
| Normal-vs-Age(81-100Yrs) |
1.31449999996036E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.638240E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.200200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.688800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.288800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.706000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.826600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.35590049877533E-10 |
| Classical-VS-Follicular |
2.8368418725222E-12 |
| Classical-VS-Other |
2.476000E-01 |
| Classical-VS-Normal |
1.62447832963153E-12 |
| Tall-VS-Follicular |
1.62436730732907E-12 |
| Tall-VS-Other |
2.269200E-01 |
| Tall-VS-Normal |
<1E-12 |
| Follicular-VS-Other |
4.92149999997693E-06 |
| Follicular-VS-Normal |
8.38630000000729E-05 |
| Other-VS-Normal |
2.57499999101185E-09 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.62447832963153E-12 |
| Normal-vs-N1 |
<1E-12 |
| N0-vs-N1 |
2.28259999999203E-05 |
|
|
